HOME >> BIOLOGY >> NEWS
Hormonal male contraception reversible after few months for all men

With hormonal male contraception likely to be available in the near future, results of a study in this week's issue of THE LANCET highlight how such contraception is reversible within a few months.

Currently available male contraceptive methods (condoms, withdrawal, and vasectomy) are not acceptable to many couples because they are either not sufficiently reliable or not easily reversible. In a similar way to ovulation suppression by hormone treatment in women, sperm production can be fully inhibited by androgen or androgen-progestagen treatment combinations in men. With such hormone treatment, azoospermia (no sperm in ejaculate) or severe oligozoospermia (less than 3 million sperm per mL of semen), which is sufficient for contraceptive purposes, can be achieved. Currently, a large phase III study with an androgen treatment and a large, multicentre phase II study of androgen-progestagen combinations are being completed in China and Europe, respectively.

Peter Liu from the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), who is currently located at the ANZAC Research Institute, University of Sydney, Australia, and colleagues analysed data from individual participants in 30 studies published in 19902005, in which sperm output was monitored every month until recovery. The primary outcome was the time for the sperm concentration to recover to a threshold of 20 million per mL, an indicator of fertility.

Data were available for around 1500 men. The average time for sperm recovery to 20 million/mL was 34 months. Various factors were associated with higher rates of recovery including older age, Asian origin, shorter treatment duration, and higher sperm concentrations at baseline. Although these factors modulated the speed of recovery, spermatogenesis recovered to levels compatible with fertility in all men.

Dr Liu and colleagues comment: "Our data provide strong assurance that the previously described ef
'"/>

Contact: Christina Wang, MD
wang@labiomed.org
310-222-2503
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
27-Apr-2006


Page: 1 2

Related biology news :

1. Hormonal signaling in the brain: radical shift in understanding information processing
2. Male contraception -- UVa discovery stirring interest among basic scientists and drug developers
3. Male contraception: One door opens, another closes
4. Queens contraception awareness program among worlds top five
5. Genetic hearing loss may be reversible without gene therapy
6. Cancer cells suppress large regions of DNA by a reversible process that can be tackled
7. Rewind, please: Nature paper shows that cell division is reversible
8. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
9. Brains hearing center may reorganize after implant of cochlear device
10. Expert to provide update after worst tomato virus hits California
11. Losing weight after pregnancy -- diet and exercise better than diet alone

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... RESTON, Va. (PRWEB) , ... August 14, 2018 ... ... stigmas were recently depicted in the movie “Wonder,” to a better understanding of ... defects treatments, according to editors of the latest special issue of Birth ...
(Date:8/7/2018)... EDWARDSVILLE, Ill. (PRWEB) , ... August 06, 2018 ... ... corn growing in front of The NCERC at Southern Illinois University Edwardsville’s University ... corn, but also grain sorghum and sweet sorghum. These three feedstocks represent conventional ...
(Date:8/2/2018)... ... August 02, 2018 , ... The ... innovator Boston Heart Diagnostics to its Lifestyle Medicine Corporate Roundtable, a group of ... care system and a sustainable world. , Boston Heart is transforming the ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... MATEO, Calif. (PRWEB) , ... July 25, 2018 ... ... for in vivo research utilizing its state-of-the-art Digital Vivarium™ and Vium Cloud approach ... Schaevitz, Ph.D., to Chief Scientific Officer. Additionally, the company announced the appointment of ...
(Date:7/25/2018)... ... July 25, 2018 , ... John McDonald, CEO ... board of the Indiana India Business Council (IIBC), an advocacy group to strengthen ... current board of directors, McDonald joins an impressive roster of local and national ...
(Date:7/24/2018)... ... July 24, 2018 , ... Boval was founded in 1978 ... reagent suppliers. In Boval’s early days most of the BSA manufactured was for ... BSA for diagnostic purposes after gel cards changed that market and displaced most of ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech ... with Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under ... SkQ1 with approximately $17m allocated towards the first Phase 3 study starting as ...
Breaking Biology Technology:
Cached News: